Management of Dry Eye Disease

Dr Laura Periman, MD illustrates the current risk factors and prevalence regarding patients with dry eye disease.

Quality-of-life concerns, including biopsychosocial impacts caused by dry eye disease, are explored by Dr Periman.

Dr Periman addresses cost-related concerns associated with treating dry eye disease.

Various treatments for dry eye disease are navigated with regard to both payer and provider considerations.

Dr Laura Periman introduces current and upcoming pharmacological treatment options, including nasal varenicline, for patients with dry eye disease.

Dr Periman provides final thoughts exploring unmet clinical needs as well as forthcoming innovative opportunities in dry eye disease treatment.